Erythropoietin linked to improved hemoglobin levels in knee or hip arthroplasty

11/13/2013 | Healio (free registration)

Use of erythropoietin-stimulating agents before elective knee and hip arthroplasty is linked to higher hemoglobin levels and reduced need for allogeneic blood transfusion, according to a new review. Results of the study published in the Journal of Arthroplasty showed a mean hemoglobin level increase of 7.16 grams per liter among those who received ESA, and the authors reported no difference in the risk of thromboembolism.

View Full Article in:

Healio (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Financial Officer
B. E. Smith
Miramar, FL
Claims Director
Springfield, OR
Attest Health Care Advisors
Nationwide, SL_Nationwide
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA